You can buy or sell Zai Lab and other stocks, options, ETFs, and crypto commission-free!
Zai Lab Limited American Depositary Shares, also called Zai Lab, is a biopharmaceutical company, which engages in the licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need. Its product pipelines include ZL-2306, ZL-2401, FPA144, ETX2514, and ZL-2301. Read More The company was founded by Samantha Ying Du and Marietta Wu in 2014 and is headquartered in Shanghai, China.
52 Week High
52 Week Low
Simply Wall StMar 13
Does Zai Lab’s (NASDAQ:ZLAB) Share Price Gain of 36% Match Its Business Performance?
These days it’s easy to simply buy an index fund, and your returns should (roughly) match the market. But one can do better than that by picking better than average stocks (as part of a diversified portfolio). For example, the Zai Lab Limited (NASDAQ:ZLAB) share price is up 36% in the last year, clearly besting than the market return of around 0.6% (not including dividends). If it can keep that out-performance up over the long term, investors will do very well! Zai Lab hasn’t been listed for long, so it’s s...
Stock Price, News, & Analysis for Zai Lab
Zai Lab Limited, a biopharmaceutical company, engages in discovering or licensing, developing, and commercializing proprietary therapeutics that address medical needs in the fields of oncology, and autoimmune and infectious disease therapies in the People's Republic of China.
Expected May 1, Pre-Market